Shelsey Johnson is a Respiratory physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 62 publications with 439 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Brigham And Women'S Hospital
15 Francis Street, Pbb Ca3
Boston, MA 02115
Telephone
617-525-9733Provider last certified this registry record 29 Aug 2024.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20231 payment
- United Therapeutics CorporationProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
47.7%Loop diuretic47.7%Furosemide100%Part D<11 patientsMetabolism & gastrointestinal
27.3%SGLT2 inhibitor27.3%Jardiance100%Part D<11 patientsRespiratory
25%Corticosteroid25%Symbicort100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2022–2025 per NIH RePORTER. The latest:
- Computed tomography for early detection and phenotyping of pulmonary hypertension associated with chronic obstructive pulmonary disease with implications for treatment
Brigham and Women'S Hospital
FY2025$171,858K23HL179493 - Novel methods to sub-phenotype patients with pulmonary hypertension due to chronic lung disease with implications for treatment
Boston University Medical Campus
FY2022$80,746F32HL164090
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pulmonary vascular features on chest computed tomography differentially associate with adverse outcomes in smokers in COPDGene
Annals of the American Thoracic Society
2025 - Pulmonary Hypertension Care Delivery in the United States: Is It Time to Get with the Guidelines?
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”